Division of Molecular Medicine
The mission of the Division of Molecular Medicine is to expand and enhance our knowledge of the nature of diseases and to develop and improve new strategies for the diagnosis, treatment and prevention of disease.
The mission of DMM is closely correlated with the major areas of human medicine, covering a broad spectrum reflected in the name of its laboratories.
The majority of research topics have been oriented to the molecular aspects of cancer, neuroscience (neuropsychiatry, neurodegeneration, neuropharmacology), stress-related diseases and their models. Particular attention and research has been devoted to mechanisms of disease etiology through disturbed methylation of macromolecules (DNA/proteins), molecular mechanisms of disease etiopathogenesis and experimental therapy.
The DMM, with its Human Tumor Bank and numerous clinical samples collected through collaborations with clinicians (e.g. in neuropsychyatry and neurodegeneration), represents an important biomedical core, dedicated to establishing and refining new strategies and methods for understanding the molecular mechanisms of disease, for improving diagnostic procedures and therapies and, of primary importance, for disease prevention.